Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity

Molecular and Cellular Biology

Volumn 27, Issue 1, 2007, Pages 220-228

  Xu, Wanping ^a   Yuan, Xitong ^a,c   Beebe, Kristin ^a   Xiang, Zhexin ^b   Neckers, Len ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEAT SHOCK PROTEIN 90; PROTEASOME; PROTEIN TYROSINE KINASE; TYROSINE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; COMPUTER MODEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STABILITY; HUMAN; HUMAN CELL; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; UPREGULATION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; RECEPTOR, ERBB-2; SRC-FAMILY KINASES; TYROSINE; UP-REGULATION;

EID: 33845804718     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00899-06     Document Type: Article

References (40)

1. Aifa, S., N. Miled, F. Frikha, M. R. Aniba, S. P. Svensson, and A. Rebai. 27 December 2006. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation. Proteins. 62:1036-1043.
2. Bagossi, P., G. Horvath, G. Vereb, J. Szollosi, and J. Tozser. 2005. Molecular modeling of nearly full-length ErbB2 receptor. Biophys. J. 88:1354-1363.
3. Belsches-Jablonski, A. P., J. S. Biscardi, D. R. Peavy, D. A. Tice, D. A. Romney, and S. J. Parsons. 2001. Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene 20:1465-1475.
4. Biscardi, J. S., M. C. Maa, D. A. Tice, M. E. Cox, T. H. Leu, and S. J. Parsons. 1999. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274:8335-8343.
5. Bouyain, S., P. A. Longo, S. Li, K. M. Ferguson, and D. J. Leahy. 2005. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. Proc. Natl. Acad. Sci. USA 102:15024-15029.
6. Burgess, A. W., H. S. Cho, C. Eigenbrot, K. M. Ferguson, T. P. Garrett, D. J. Leahy, M. A. Lemmon, M. X. Sliwkowski, C. W. Ward, and S. Yokoyama. 2003. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell 12:541-552.
7. Cabioglu, N., J. Summy, C. Miller, N. U. Parikh, A. A. Sahin, S. Tuzlali, K. Pumiglia, G. E. Gallick, and J. E. Price. 2005. CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res. 65:6493-6497.
8. Chan, A. C., M. Dalton, R. Johnson, G. H. Kong, T. Wang, R. Thoma, and T. Kurosaki. 1995. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 14:2499-2508.
9. Chantry, A. 1995. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J. Biol. Chem. 270:3068-3073.
10. Chavany, C., E. Mimnaugh, P. Miller, R. Bitton, P. Nguyen, J. Trepel, L. Whitesell, R. Schnur, J. Moyer, and L. Neckers. 1996. p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. J. Biol. Chem. 271:4974-4977.
11. Citri, A., J. Gan, Y. Mosesson, G. Vereb, J. Szollosi, and Y. Yarden. 2004. Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation. EMBO Rep. 5:1165-1170.
12. Diermeier, S., G. Horvath, R. Knuechel-Clarke, F. Hofstaedter, J. Szollosi, and G. Brockhoff. 2005. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp. Cell Res. 304:604-619.
13. Donze, O., T. Abbas-Terki, and D. Picard. 2001. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 20:3771-3780.
14. Hubbard, S. R. 1997. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16:5572-5581.
15. Huse, M., and J. Kuriyan. 2002. The conformational plasticity of protein kinases. Cell 109:275-282.
16. Jeffrey, P. D., L. Tong, and N. P. Pavletich. 2000. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev. 14:3115-3125.
17. Juang, S. H., M. E. Carvajal, M. Whitney, Y. Liu, and C. A. Carraway. 1996. Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein. Oncogene 12:1033-1042.
18. Kim, H., R. Chan, D. L. Dankort, D. Zuo, M. Najoukas, M. Park, and W. J. Muller. 2005. The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. Oncogene 24:7599-7607.
19. Landau, M., S. J. Fleishman, and N. Ben-Tal. 2004. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. Structure 12:2265-2275.
20. Leahy, D. J. 2004. Structure and function of the epidermal growth factor (EGF/ErbB) family of receptors. Adv. Protein Chem. 68:1-27.
21. Lombardo, C. R., T. G. Consler, and D. B. Kassel. 1995. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites. Biochemistry 34:16456-16466.
22. Luttrell, L. M., B. E. Hawes, T. van Biesen, D. K. Luttrell, T. J. Lansing, and R. J. Lefkowitz. 1996. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J. Biol. Chem. 271:19443-19450.
23. Mimnaugh, E. G., C. Chavany, and L. Neckers. 1996. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J. Biol. Chem. 271:22796-22801.
24. Murali, R., P. J. Brennan, T. Kieber-Emmons, and M. I. Greene. 1996. Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains. Proc. Natl. Acad. Sci. USA 93:6252-6257.
25. Muthuswamy, S. K., and W. J. Muller. 1995. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Oncogene 11:1801-1810.
26. Muthuswamy, S. K., and W. J. Muller. 1995. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene 11:271-279.
27. Pero, S. C., G. S. Shukla, A. L. Armstrong, D. Peterson, S. P. Fuller, K. Godin, S. L. Kingsley-Richards, D. L. Weaver, J. Bond, and D. N. Krag. 2004. Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells. Int. J. Cancer 111:951-960.
28. Roskoski, R., Jr. 2005. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 331:1-14.
29. Sabri, A., J. Guo, H. Elouardighi, A. L. Darrow, P. Andrade-Gordon, and S. F. Steinberg. 2003. Mechanisms of protease-activated receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase. J. Biol. Chem. 278:11714-11720.
30. Schlaepfer, D. D., and S. K. Mitra. 2004. Multiple connections link FAK to cell motility and invasion. Curr. Opin. Genet. Dev. 14:92-101.
31. Stamos, J., M. X. Sliwkowski, and C. Eigenbrot. 2002. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277:46265-46272.
32. Stover, D. R., M. Becker, J. Liebetanz, and N. B. Lydon. 1995. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. J. Biol. Chem. 270:15591-15597.
33. Thomas, S. M., and J. S. Brugge. 1997. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13:513-609.
34. Tice, D. A., J. S. Biscardi, A. L. Nickles, and S. J. Parsons. 1999. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 96:1415-1420.
35. Xiang, Z., and B. Honig. 2001. Extending the accuracy limits of prediction for side-chain conformations. J. Mol. Biol. 311:421-430.
36. Xiang, Z., C. S. Soto, and B. Honig. 2002. Evaluating conformational free energies: the colony energy and its application to the problem of loop prediction. Proc. Natl. Acad. Sci. USA 99:7432-7437.
37. Xu, W., E. Mimnaugh, M. F. Rosser, C. Nicchitta, M. Marcu, Y. Yarden, and L. Neckers. 2001. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J. Biol. Chem. 276:3702-3708.
38. Xu, W., X. Yuan, Z. Xiang, E. Mimnaugh, M. Marcu, and L. Neckers. 2005. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex. Nat. Struct. Mol. Biol. 12:120-126.
39. Zhang, H. T., D. M. O'Rourke, H. Zhao, R. Murali, Y. Mikami, J. G. Davis, M. I. Greene, and X. Qian. 1998. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential. Oncogene 16:2835-2842.
40. Zhang, K., J. Sun, N. Liu, D. Wen, D. Chang, A. Thomason, and S. K. Yoshinaga. 1996. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J. Biol. Chem. 271:3884-3890.